Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Buy

Exponential Moving Average

Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Eledon Pharmaceuticals, Inc. Common Stock (ELDN)

Pharmaceutical Preparations

https://www.eledon.com

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

19900 MACARTHUR BLVD., SUITE 550
IRVINE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/17/2014

Market Cap

104,545,419

Shares Outstanding

24,200,000

Weighted SO

24,198,130

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

INZY --.--%

DAWN --.--%

TERN --.--%

HOOK --.--%

XFOR --.--%

ABOS --.--%

AMLX --.--%

MREO --.--%

Beta

0.9120

Last Div

0.0000

Range

1.07-3.349

Chg

-0.0250

Avg Vol

138838

Mkt Cap

104545419

Exch

NASDAQ

Country

US

Phone

949 238 8090

DCF Diff

2.6043

DCF

0.1718

Div Yield

0.0000

P/S

0.0000

EV Multiple

-2.3400

P/FV

1.0882

Div Yield %

0.0000

P/E

-2.0432

PEG

-0.0279

Payout

0.0000

Current Ratio

11.2967

Quick Ratio

11.2967

Cash Ratio

1.3315

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1804.6684

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0052

ROA

-0.4931

ROE

-0.4560

ROCE

-0.5584

NI/EBT

1.0000

EBT/EBIT

0.9319

EBIT/Rev

0.0000

Debt Ratio

0.0035

D/E

0.0038

LT Debt/Cap

0.0000

Total Debt/Cap

0.0038

Int Coverage

0.0000

CF/Debt

-135.0141

Equity Multi

1.0802

Rec Turnover

0.0000

Pay Turnover

0.2023

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.2786

FCF/Share

-1.2786

Cash/Share

1.4292

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-135.0141

ST Coverage

-135.0141

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.0882

P/B

1.0882

P/S

0.0000

P/E

-2.0432

P/FCF

-2.7265

P/OCF

-2.1234

P/CF

-2.1234

PEG

-0.0279

P/S

0.0000

EV Multiple

-2.3400

P/FV

1.0882

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 04, 16:40 Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook GlobeNewswire Inc. Dec 04, 18:00 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Dec 04, 18:00 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Dec 04, 18:00 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Dec 04, 18:00 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Dec 04, 18:00 Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Benzinga Nov 13, 10:00 Expert Ratings for Eledon Pharma

Revenue Product Segmentation